![3 weeks treatment with TAS-116 ameliorates HCl-induced activation of... | Download Scientific Diagram 3 weeks treatment with TAS-116 ameliorates HCl-induced activation of... | Download Scientific Diagram](https://www.researchgate.net/publication/365226172/figure/fig4/AS:11431281096384523@1668123843823/weeks-treatment-with-TAS-116-ameliorates-HCl-induced-activation-of-pro-fibrotic-pathways_Q320.jpg)
3 weeks treatment with TAS-116 ameliorates HCl-induced activation of... | Download Scientific Diagram
![TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours | British Journal of Cancer TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-019-0688-y/MediaObjects/41416_2019_688_Fig3_HTML.png)
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours | British Journal of Cancer
![Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm](https://ars.els-cdn.com/content/image/1-s2.0-S0959804919304691-gr2.jpg)
Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells | PLOS ONE
![Histological analysis of IM and TAS-116 in GIST cell xenograft mouse... | Download Scientific Diagram Histological analysis of IM and TAS-116 in GIST cell xenograft mouse... | Download Scientific Diagram](https://www.researchgate.net/publication/338068144/figure/fig1/AS:1021636329361408@1620588490608/Histological-analysis-of-IM-and-TAS-116-in-GIST-cell-xenograft-mouse-models-a_Q320.jpg)
Histological analysis of IM and TAS-116 in GIST cell xenograft mouse... | Download Scientific Diagram
![TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours | British Journal of Cancer TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-019-0688-y/MediaObjects/41416_2019_688_Fig1_HTML.png)
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours | British Journal of Cancer
![Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis - ScienceDirect Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332222006369-ga1.jpg)
Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis - ScienceDirect
![TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours | British Journal of Cancer TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-019-0688-y/MediaObjects/41416_2019_688_Fig2_HTML.png)
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours | British Journal of Cancer
![Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors | Journal of Medicinal Chemistry Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c01715/asset/images/medium/jm0c01715_0005.gif)
Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors | Journal of Medicinal Chemistry
![Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma | Leukemia Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fleu.2014.300/MediaObjects/41375_2015_Article_BFleu2014300_Fig1_HTML.jpg)
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma | Leukemia
![IJMS | Free Full-Text | TAS-116, a Well-Tolerated Hsp90 Inhibitor, Prevents the Activation of the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells IJMS | Free Full-Text | TAS-116, a Well-Tolerated Hsp90 Inhibitor, Prevents the Activation of the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells](https://pub.mdpi-res.com/ijms/ijms-22-04875/article_deploy/html/images/ijms-22-04875-g003.png?1620201001)
IJMS | Free Full-Text | TAS-116, a Well-Tolerated Hsp90 Inhibitor, Prevents the Activation of the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells
![IJMS | Free Full-Text | TAS-116, a Well-Tolerated Hsp90 Inhibitor, Prevents the Activation of the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells IJMS | Free Full-Text | TAS-116, a Well-Tolerated Hsp90 Inhibitor, Prevents the Activation of the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells](https://www.mdpi.com/ijms/ijms-22-04875/article_deploy/html/images/ijms-22-04875-g006-550.jpg)
IJMS | Free Full-Text | TAS-116, a Well-Tolerated Hsp90 Inhibitor, Prevents the Activation of the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells
![TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation | Semantic Scholar TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0a249e15cd8c673cda8ef09103ccc9ea14905bf2/5-Figure4-1.png)
TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation | Semantic Scholar
![TAS‐116 (pimitespib), a heat shock protein 90 inhibitor, shows efficacy in preclinical models of adult T‐cell leukemia - Ikebe - 2022 - Cancer Science - Wiley Online Library TAS‐116 (pimitespib), a heat shock protein 90 inhibitor, shows efficacy in preclinical models of adult T‐cell leukemia - Ikebe - 2022 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a31278c0-d5bd-47b8-98ea-b5d983bd758e/cas15204-fig-0002-m.jpg)
TAS‐116 (pimitespib), a heat shock protein 90 inhibitor, shows efficacy in preclinical models of adult T‐cell leukemia - Ikebe - 2022 - Cancer Science - Wiley Online Library
![IJMS | Free Full-Text | TAS-116, a Well-Tolerated Hsp90 Inhibitor, Prevents the Activation of the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells IJMS | Free Full-Text | TAS-116, a Well-Tolerated Hsp90 Inhibitor, Prevents the Activation of the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells](https://pub.mdpi-res.com/ijms/ijms-22-04875/article_deploy/html/images/ijms-22-04875-ag.png?1620265428)